Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,789 | 102 | 99.3% |
| Education | $20.52 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $641.14 | 16 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $411.61 | 26 | $0 (2024) |
| Lilly USA, LLC | $295.58 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.66 | 5 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $185.06 | 2 | $0 (2023) |
| Novo Nordisk Inc | $170.33 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $130.78 | 2 | $0 (2021) |
| PFIZER INC. | $122.83 | 2 | $0 (2020) |
| Amgen Inc. | $118.82 | 2 | $0 (2022) |
| Axsome Therapeutics, Inc. | $90.31 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.57 | 8 | AstraZeneca Pharmaceuticals LP ($123.58) |
| 2023 | $312.59 | 9 | OPKO Pharmaceuticals, LLC ($185.06) |
| 2022 | $231.96 | 8 | Amgen Inc. ($100.80) |
| 2021 | $454.07 | 30 | Kowa Pharmaceuticals America, Inc. ($134.46) |
| 2020 | $261.58 | 14 | Lilly USA, LLC ($114.64) |
| 2019 | $270.95 | 6 | Amarin Pharma Inc. ($116.94) |
| 2018 | $580.56 | 17 | Kowa Pharmaceuticals America, Inc. ($175.92) |
| 2017 | $463.88 | 12 | Amarin Pharma Inc. ($257.66) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $123.58 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 02/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/05/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/20/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Neurology | ||||||
| 11/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Obesity | ||||||
| 10/31/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Neurology | ||||||
| 05/18/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $135.06 | General |
| Category: NEPHROLOGY | ||||||
| 05/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 05/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/10/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: NEPHROLOGY | ||||||
| 09/14/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Inflammation | ||||||
| 09/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 08/10/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.15 | General |
| Category: Cardiovascular | ||||||
| 04/06/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Central Nervous System | ||||||
| 03/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardio-renal | ||||||
| 02/03/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Central Nervous System | ||||||
| 01/18/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 312 | 636 | $51,700 | $29,175 |
| 2022 | 10 | 338 | 684 | $53,240 | $31,534 |
| 2021 | 10 | 331 | 724 | $53,960 | $31,572 |
| 2020 | 10 | 367 | 815 | $55,325 | $31,048 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 163 | $24,450 | $14,963 | 61.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 51 | $5,100 | $3,866 | 75.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 52 | $5,720 | $2,912 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,600 | $2,409 | 66.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 51 | $1,530 | $1,499 | 98.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 19 | 56 | $2,800 | $1,481 | 52.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 113 | $5,650 | $1,186 | 21.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 34 | 70 | $1,750 | $572.74 | 32.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $600.00 | $231.36 | 38.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 15 | 50 | $500.00 | $54.94 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 167 | $25,050 | $16,213 | 64.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 54 | 55 | $4,125 | $3,864 | 93.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 65 | $7,150 | $3,707 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $3,000 | $2,071 | 69.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 22 | 69 | $3,450 | $1,911 | 55.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 54 | $1,620 | $1,588 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 114 | $5,700 | $1,266 | 22.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 35 | 81 | $2,025 | $611.13 | 30.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $600.00 | $236.00 | 39.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 16 | 52 | $520.00 | $67.08 | 12.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 165 | $24,525 | $16,475 | 67.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 58 | $6,260 | $3,502 | 55.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 49 | 49 | $3,675 | $3,255 | 88.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $3,800 | $2,682 | 70.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 25 | 74 | $3,700 | $2,094 | 56.6% |
About Dr. John Zaro, DO
Dr. John Zaro, DO is a Family Medicine healthcare provider based in Norristown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720096571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Zaro, DO has received a total of $2,809 in payments from pharmaceutical and medical device companies, with $233.57 received in 2024. These payments were reported across 104 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,789).
As a Medicare-enrolled provider, Zaro has provided services to 1,348 Medicare beneficiaries, totaling 2,859 services with total Medicare billing of $123,329. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Norristown, PA
- Active Since 08/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720096571
Products in Payments
- Vascepa (Drug) $641.14
- Livalo (Drug) $397.89
- RAYALDEE (Drug) $185.06
- FARXIGA (Drug) $146.08
- XARELTO (Drug) $130.78
- AIRSUPRA (Drug) $123.58
- JARDIANCE (Drug) $115.52
- ELIQUIS (Drug) $110.44
- Otezla (Drug) $100.80
- TRULICITY (Drug) $83.20
- XIFAXAN (Drug) $78.53
- Saxenda (Drug) $76.90
- Ozempic (Drug) $63.36
- Auvelity (Drug) $57.86
- AUSTEDO (Drug) $51.58
- BELBUCA (Drug) $34.71
- Sunosi (Drug) $32.45
- Wegovy (Drug) $30.07
- SUNOSI (Drug) $27.31
- Kerendia (Drug) $21.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Norristown
Dr. Christopher Malsch, D.o, D.O
Family Medicine — Payments: $25,288
Dr. Eric Yeh, M.d, M.D
Family Medicine — Payments: $4,497
Sabeena Fazili, M.d, M.D
Family Medicine — Payments: $2,414
Mr. Joseph Cipriano, Md, MD
Family Medicine — Payments: $2,181
Dr. James Watson, Do, DO
Family Medicine — Payments: $1,362
Christopher Drumm, M.d, M.D
Family Medicine — Payments: $1,147